Hip region muscular dystrophy and emergence of motor deficits in dysferlin‐deficient Bla/J mice

The identification of a dysferlin‐deficient animal model that accurately displays both the physiological and behavior aspects of human dysferlinopathy is critical for the evaluation of potential therapeutics. Disease progression in dysferlin‐deficient mice is relatively mild, compared to the debilit...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Physiological reports 2017-03, Vol.5 (6), p.np-n/a
Hauptverfasser: Nagy, Nadia, Nonneman, Randal J., Llanga, Telmo, Dial, Catherine F., Riddick, Natallia V., Hampton, Tom, Moy, Sheryl S., Lehtimäki, Kimmo K., Ahtoniemi, Toni, Puoliväli, Jukka, Windish, Hillarie, Albrecht, Douglas, Richard, Isabelle, Hirsch, Matthew L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The identification of a dysferlin‐deficient animal model that accurately displays both the physiological and behavior aspects of human dysferlinopathy is critical for the evaluation of potential therapeutics. Disease progression in dysferlin‐deficient mice is relatively mild, compared to the debilitating human disease which manifests in impairment of particular motor functions. Since there are no other known models of dysferlinopathy in other species, locomotor proficiency and muscular anatomy through MRI (both lower leg and hip region) were evaluated in dysferlin‐deficient B6.A‐Dysfprmd/GeneJ (Bla/J) mice to define disease parameters for therapeutic assessment. Despite the early and progressive gluteal muscle dystrophy and significant fatty acid accumulation, the emergence of significant motor function deficits was apparent at approximately 1 year of age for standard motor challenges including the rotarod, a marble bury test, grip strength, and swimming speed. Earlier observations of decreased performance for Bla/J mice were evident during extended monitoring of overall exploration and rearing activity. Comprehensive treadmill gait analyses of the Bla/J model indicated significant differences in paw placement angles and stance in relation to speed and platform slope. At 18 months of age, there was no significant difference in the life expectancy of Bla/J mice compared to wild type. Consistent with progressive volume loss and fatty acid accumulation in the hip region observed by MRI, mass measurement of individual muscles confirmed gluteal and psoas muscles were the only muscles demonstrating a significant decrease in muscle mass, which is analogous to hip‐girdle weakness observed in human dysferlin‐deficient patients. Collectively, this longitudinal analysis identifies consistent disease parameters that can be indicators of efficacy in studies developing treatments for human dysferlin deficiency. There is no known cure for dysferlinopathy and its incidence remains poorly characterized yet more prevalent than originally thought as increasingly diagnosed by genetic testing. Limited animal models of dysferlinopathy exist, however, remain largely uncharacterized. The current body of work identifies consistent disease parameters of the Bla/J mouse model as universal benchmarks for development of a therapy for dysferlinopathy.
ISSN:2051-817X
2051-817X
DOI:10.14814/phy2.13173